Advertisement
 
YOU ARE HERE: LAT HomeCollectionsAllergan Inc
IN THE NEWS

Allergan Inc

BUSINESS
November 2, 2006 | From the Associated Press
Allergan Inc., maker of breast implants and Botox anti-wrinkle treatment, said quarterly profit fell 29% because of restructuring expenses and costs associated with its acquisition of Inamed Corp. The Irvine-based company, which also makes eye medications, said third-quarter net income was $106.4 million, or 70 cents a share, down from $150.5 million, or $1.12, a year earlier. Before exceptional items, the company earned 95 cents a share.
Advertisement
BUSINESS
May 25, 1993
Allergan Inc., a provider of eye-care and other medical products, said it has agreed to conduct joint clinical trials of drugs with Summit Technology Inc. The companies will conduct joint clinical trials of certain drugs for use after a surgical procedure known as photorefractive keratectomy. The procedure involves the use of a laser to correct eye disorders such as nearsightedness, farsightedness and astigmatism.
BUSINESS
January 24, 2006 | From Reuters
Botox maker Allergan Inc. said it was extending its $3.2-billion offer to buy breast implant maker Inamed Corp. because it had yet to get antitrust clearance from regulators. The offer is now set to expire at 8 p.m. on Feb. 7; it had been set to expire today. Irvine-based Allergan and Santa Barbara-based Inamed said they were working with the Federal Trade Commission to complete the sale of Inamed's license for Reloxin, a botulism toxin product.
Los Angeles Times Articles
|